Arcutis Biotherapeutics Inc (ARQT) — Financial Flexibility Index
Arcutis Biotherapeutics Inc (ARQT) has a Financial Flexibility Index of 0.05x as of June 2026. Free cash flow of $12.80 Million (operating CF $12.64 Million minus capex $158.00K) represents 0% of total liabilities ($267.96 Million). Check total reinvestment intensity of Arcutis Biotherapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Arcutis Biotherapeutics Inc Financial Flexibility Index (2017–2025)
Historical Financial Flexibility Index trend for Arcutis Biotherapeutics Inc across 9 annual periods. For the full cash flow conversion analysis, see ARQT cash flow conversion.
Annual Financial Flexibility Index for Arcutis Biotherapeutics Inc (2017–2025)
Year-by-year free cash flow to debt coverage for Arcutis Biotherapeutics Inc. Explore debt repayment capacity of Arcutis Biotherapeutics Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.02x | $-4.94 Million | $-5.62 Million | $243.49 Million | ▲ +96.5% |
| 2024 | -0.59x | $-112.02 Million | $-112.16 Million | $191.35 Million | ▲ +40.0% |
| 2023 | -0.98x | $-246.63 Million | $-247.06 Million | $252.70 Million | ▲ +0.2% |
| 2022 | -0.98x | $-234.43 Million | $-257.71 Million | $239.69 Million | ▲ +37.8% |
| 2021 | -1.57x | $-173.63 Million | $-174.63 Million | $110.47 Million | ▲ +61.4% |
| 2020 | -4.08x | $-112.71 Million | $-113.03 Million | $27.65 Million | ▲ +46.8% |
| 2019 | -7.67x | $-42.54 Million | $-42.84 Million | $5.55 Million | ▼ -4073.5% |
| 2018 | -0.18x | $-13.79 Million | $-14.09 Million | $75.08 Million | ▲ +53.5% |
| 2017 | -0.39x | $-3.48 Million | $-3.77 Million | $8.81 Million | — |